市場調査報告書：細胞と組織培養関連サプライの世界市場

Abstract

This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in Millions of US$. The specific product segments analyzed are Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 110 companies including many key and niche players worldwide such as AMRESCO, Inc., Analytical Biological Services, BD Biosciences, Cambrex Bioscience Walkersville, Inc., Cell Culture Technologies, Cell Essentials, MP Biomedicals, Invitrogen, Irvine Scientific, JRH Biosciences, Kemp Biotechnologies, Mediatech, Inc., Medi-Cult, PerBio Science, PromoCell, Sera Laboratories International, Serologicals Corp., Sigma-Aldrich, SAFC Biosciences, USB Corp., Vitrolife AB, and Wisent, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-2
Product Definitions and Scope of Study I-3
Cell/Tissue Culture Media, Sera and Reagents I-3

II. EXECUTIVE SUMMARY

1. Market Dynamics II-1

Outlook II-1
Biopharmaceutical Drugs Fuel Cell Culture Market II-1
Market Scenario II-2
Industrial vs. Academic II-2
Segmental Outlook II-2
Regional Perspective II-3
Market Structure II-3
Leading Players II-3
Table 1: Leading Players in US Cell/Tissue Culture Market (2003, 2004, & 2005E): Percentage Breakdown of Value Sales for Invitrogen, JRH Biosciences, Hyclone, Cambrex Bio Science Walkersville (Formerly BioWhittaker), Sigma-Aldrich, and Others (includes corresponding Graph/Chart) II-3

2. Trends and Issues II-4

Surging Demand for Cell Culture Products II-4
Changing Trend Towards Serum-Free Media II-4
Proteomics and Pharmacokinetics Drive Market Growth II-4
CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture II-6
Sluggish Fetal Bovine Serum Market II-6
Cell Therapy Market Witnesses Increasing Consolidation Activity II-6
Specialty Media Growing in Demand II-6
Emerging Alternatives to Conventional Serum Supplemented Media II-7
Growth of Defined Media II-7
Regulations Prompt Change in Trends II-7
Media Optimization II-7
Other Trends II-8
Manufacture-on-Demand: Gaining Momentum II-8
Move Towards Contract Manufacturing II-8
Factors Impacting Growth II-8
Business Models Driving the Need for Contract Manufacturing II-9
Trends in Contract Manufacturing II-9
Target Sectors for Contract Manufacturers II-9

3. End Use Analysis II-10

End Use Applications II-10
Cell Therapy II-10
Growing by Leaps and Bounds II-10
Cell Therapy Applications II-11
Key Factors Affecting the Cell Therapy Market II-11
Future Trends II-11
Related Market Sectors II-11
Progenitor Cell Therapy II-11
Table 2: US Market for Progenitor Cell Therapy (2003 & 2004): Annual Sales in US$ Million for Blood Cells; Skin, Bone and Cartilage; and Others (includes corresponding Graph/Chart) II-12
Table 3: US Market for Progenitor Cell Therapy (2003 & 2004): Percentage Breakdown by Value Sales for Blood Cells; Skin, Bone and Cartilage; and
Others (includes corresponding Graph/Chart) II-12
Stem Cell Therapy II-12
Scope and Applications II-13
Other Related Technologies II-13
Somatic Cell Nuclear Transfer (SCNT) II-13
Tissue Engineering II-13
End Use Industries II-13

4. Cell/Tissue Culture: Physiological Overview II-14

Introduction II-14
History II-14
Plant Cell and Tissue Culture (PCTC) II-18
Cell/Tissue Culture Media, Sera and Reagents II-21
Classical Media II-21
Specialty Media II-22
Serum II-22
Fetal Bovine Serum II-22
Serum-Free Media II-22
Cell Culture Reagents II-22
Role of Tissue Culture in the Growth of Cell Types II-23
Equipment II-23
Storage and Preservation II-23
Maintenance II-23
Growth Pattern II-24
Harvesting II-24
Media and Growth Requirements II-24
Physiological Parameters II-24
Medium Requirements (Often Empirical) II-25
Feeding II-25
Safety Precautions II-25
Methods of Tissue Culture II-25
Preparation of Media II-25
Growth and Morphology II-26
Sub Culturing Adherent Cells II-26
Trypsin-EDTA II-26
EDTA Alone II-26
Thawing Frozen Cells II-26
Freezing Cells II-26
Cell Culture Contamination - A Looming Problem II-27
Classification II-27
Major Cell Culture Contaminants II-27
Chemical Contamination II-27
Types and Sources of Potential Chemical Contaminants II-27
Varied Sources of Chemical Contamination II-28
Media and Components II-28
Sera II-28
Water II-28
Storage Vessels II-29
Fluorescent Lights II-29
Endotoxins II-29
Incubators II-30
Biological Contamination II-30
Varied Sources of Biological Contamination II-30
Mycoplasmas II-31
Airborne Particles and Aerosols II-31
Cross Contamination by Other Cell Cultures II-31
Consequences/Problems of Contamination II-31
Controlling Cell Culture Contamination II-32
Measures Aimed at Reducing Contamination Problems II-32
5. Regulatory Environment II-33

6. Product Introductions/Innovations II-34

HyClone Introduces HyQ®CDM4MAb™ for Hybridoma Cell Lines II-34
INTEGRA Biosciences Adds Alarm Interface to CELLROLL and CELLSPIN Systems II-34
Nikon Launches New Imaging and Tracking Systems for Cell Culture II-34
Genetix Develops Cell Dispenser II-34
SAFC Biosciences Introduces LONGTMR3IGF-I for Industrial Cell Culture II-34
Biocrystal Presents Opticell II-35
TAP Unveils CompacT SelecT™ II-35
New Brunswick Scientific Augments New Products to Cell Culture Systems II-35
Cell Culture Technologies Develops Fortified Production Media II-35
HyClone Unveils New Microcarrier Product Line -HyQ®Spheres™ II-35
Celliance Brings Out LucraTone(TM) Peptones II-35
Millipore Offers More Products for Cell Culture Assays II-36
FibraStage™ Cell Culture System for Higher Yields II-36
Acolyte to Incorporate AK Rapid® technology BacLite RapiTECT™ Range II-36
Ventria Bioscience Unveiled Lacromin™ for Cell Culture Media II-36
Vivascience Launches Vivadish II-36
Celliance Corporation Unveils Hybri-CYTE(TM) II-37

7. Recent Industry Activity II-38

SAFC-Biosciences Forms to Support Sigma-Aldrich II-38
Invitrogen and Cellartis to Co-develop hESC
Reporter Lines II-38
CELLCA and Rentschler Join Forces for Unique
High-Level Expression System II-38
ArcDia Partners with Chip-Man Technologies II-38
Chugai Pharmaceutical Receives License for Cell Line from Cambrex Bio Science Walkersville, Inc. II-38
Chemicon Inks Distribution Agreement with CELLnTEC II-39
Chemicon Signs an Agreement with ReNeuron II-39
Chemicon to Market Stem Cell Products of ASCC II-39
SCS and Chemicon Introduce ESGRO
Complete™ Product Range II-39
Serologicals Acquires Cytomyx Ltd II-39
Millipore to Take Over Serologicals II-40
CAT Opts SelectT™ for Higher Cell Culture Yields II-40
SAFC to Market Cell Line Engineering of ProBioGen II-40
Chemicon Licensed to Employ the RheoSwitch(R) System of RheoGene II-40
SCS and Chemicon Sign an Agreement for ES Cell Media II-40
Innovata Grants UCOE Gene Expression Technology to Celliance II-40
Chemicon and Axordia Collaborate for New Antibody Markers II-41
Genzyme Acquires Verigen AG II-41
Chemicon Acquires Specialty Media II-41
CalbaTech Pockets K-D Medical II-41
Sigma- Aldrich Acquires JRH Biosciences II-42
Invitrogen Acquires Dynal II-42
Invitrogen Takes Over Biosource International II-42
CellzDirect Takes Over HepatoTech II-42
BD Acquires Atto Biosciences II-43
Serologicals Corp Pockets AltaGen Biosciences II-43
Serologicals Purchases Upstate Group II-43
The Automation Partnership (TAP) Collaborates with MAIA SCIENTIFIC II-43
Cambrex Bio Science signs agreement with QBM Cell Science II-43
Serologicals Forms Celliance II-44
JRH Biosciences Opens cGMP Facility II-44
Vitrolife Bags Patent Approvals in the US and Europe II-44
C3 Receives Clearance from Japanese Ministry
of Health II-44
Fisher Scientific Acquires Perbio Science II-44
ICN Pharmaceuticals Divests Biomedicals Division II-45
Boston Scientific Enters Into a Strategic Alliance with Osiris II-45
Perbio Acquires FBS Supplier in Australia II-45
BD Biosciences Collaborates with Harvard Institute of Proteomics II-45
Serologicals in Global Distribution Agreement with Novo Nordisk II-45
Invitrogen in Licensing Agreement for CHO Cell Lines II-46
CMT Unveils New Facility at Pennsylvania II-46
Serologicals Corp Acquires Intergen Co II-46
Cambrex Acquires Bio Science Corp II-47
Anthrogenesis Acquires Atlantic Stem Cells II-47
Celmed Acquires NeuroGenomics and NeuroGeneration II-47
HyClone and Kinetics Form HyNetics LLC II-47
Aastrom Biosciences Enters Into a Co-MarketingAgreement With Bio Whittaker II-47
Vitrolife Enters Into a Co-operation Agreement with Millenium II-48
Perbio Acquires Pierce & Warriner II-48
Sigma-Aldrich Acquires Ark Scientific II-48
Sigma-Aldrich and Ajinomoto Enter Into Amino Acid
Alliance II-48SeraCare Inc. and Grupo Grifols Enter Into Plasma Supply Agreement II-49
Commonwealth Biotechnologies and Kemp
Biotechnologies Sign Letter of Intent II-49
Perbio Science Inks Agreement with Panymex International II-49
Perbio' s HyClone Laboratories Inks Agreement with China Northwestern Minorities University II-49
Perbio' s Cell Culture Division Signs Agreement with ConAgra II-49
Serologicals Expands BSA Manufacturing Facility II-49
Invitrogen Corporation Undergoes Restructuring II-50
Serologicals Divests Seramed to Aventis II-50
SeraCare Inc. Divests Consolidated Technologies II-50

8. Focus on Select Major Players II-51

AMRESCO Inc (USA) II-51
Analytical Biological Services (USA) II-51
BD Biosciences (USA) II-51
Cambrex Bio Science Walkersville, Inc (USA) II-51
Cell Culture Technologies (Switzerland) II-52
Cell Essentials (USA) II-52
MP Biomedicals (USA) II-52
Invitrogen (USA) II-52
Irvine Scientific (USA) II-53
JRH Biosciences (USA) II-53
Kemp Biotechnologies (USA) II-53
Mediatech Inc. (USA) II-53
Medi-Cult (Denmark) II-54
PerBio Science (Sweden) II-54
PromoCell (Germany) II-54
Sera Laboratories International (UK) II-54
Serologicals Corp (USA) II-55
Sigma-Aldrich (USA) II-55
SAFC Biosciences (USA) II-55
USB Corp (USA) II-55
Vitrolife AB (Sweden) II-56
Wisent Inc. (Canada) II-56

9. Global Market Perspective II-57

Table 4: World Recent Past, Current & Future Market Analysis for Cell/Tissue Culture Supplies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-57
Table 5: World 10-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-57
Table 6: World Recent Past, Current & Future Market Analysis for Media Cell/Tissue Culture Supplies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-58
Table 7: World 10-Year Perspective for Media Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-58
Table 8: World Recent Past, Current & Future Market Analysis for Sera Cell/Tissue Culture Supplies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includescorresponding Graph/Chart) II-59
Table 9: World 10-Year Perspective for Sera Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-59
Table 10: World Recent Past, Current & Future Market Analysis for Reagent Cell/Tissue Culture Supplies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-60
Table 11: World 10-Year Perspective for Reagent Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-60

II. MARKET

<>1. The United States III-1

A. Market Analysis III-1
Biotech Industry in the US III-1
Cell & Tissue Culture Market III-1
A Brief Insight III-1
Grade Definitions III-2
Market Trends III-2
Trend Towards Serum-Free Media III-2
Table 12: US Market for Cell Culture (2004): Percentage Breakdown of Value Sales for Media, Sera and Reagents by End Use Application - Industrial and Academic (includes corresponding Graph/Chart) III-3
Table 13: US Market for Cell Culture (2004): Percentage Breakdown of Value Sales by Industrial and Academic End Use Application for Liquid Media, Powdered Media, Fetal Bovine Serum, Serum-free and Protein-free Media, Growth Factors, Other Sera, Supplements, Antibiotics, and Other Products (includes corresponding Graph/Chart) III-4
Liquid and Powdered Media Account for Major Share III-4
Fetal Bovine Serum - Uses on a Decline III-4
Table 14: Leading Producers of Fetal Bovine Serum in the US (2004): Percentage Breakdown of Value Sales for Life Technologies, Hyclone, and Others (includes corresponding Graph/Chart) III-5
Bovine Serum Industry: Highly Unpredictable III-5
Suppliers Searching for New Areas III-5Sustained Rise of Serum-Free and Protein- Free Media III-5
Rise in Cell Culture Equipment Demand Leads to Innovation III-5
End Use Analysis III-6
Table 15: US Market for Cell and Tissue Culture (2004): Percentage Share by Research Application for Cellular Research, Protein Expression, Protein Production, Cell Therapy, and Cell Transplantation (includes corresponding Graph/Chart) III-6
Table 16: US Market for Cell Culture Reagents (2004): Percentage Breakdown of Value Sales for End Use Applications- Academic, Industrial, and Non-Academic (includes corresponding Graph/Chart) III-6
Table 17: Leading Players in US Cell/Tissue Culture Market (2003, 2004, & 2005E):Percentage Breakdown of Value Sales for Invitrogen, JRH Biosciences, Hyclone, Cambrex Bio Science Walkersville (Formerly BioWhittaker), Sigma-Aldrich, and Others (includes corresponding Graph/Chart) III-7
Factors Influencing the Market for Tissue and Cell Culture Media III-7
Regulatory Controls III-7
Guidelines Governing Use of Cell/Tissue Culture Reagents III-8
MSDS and Hazardous Information III-8
Toxic Substances Control Act III-8
Key Players III-8
AMRESCO Inc III-8
Analytical Biological Services III-8
BD Biosciences III-9
Cell Applications Inc III-9
Cell Essentials III-9
Cambrex Bio Science Walkersville, Inc III-9
MP Biomedicals (USA) III-10
Invitrogen III-10
Irvine Scientific III-10
Mediatech Inc III-11
Serologicals Corp III-11
Sigma-Aldrich III-11
SAFC Biosciences III-11
USB Corp III-12
Product Introductions/Innovations III-12
Strategic Developments III-16
B. Market Analytics III-24
Table 18: US Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment -Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-24
Table 19: US 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-24

2. Canada III-25

A. Market Analysis III-25
Overview III-25
Biotechnology Industry III-25
Wisent Inc - A Key Player III-25
Strategic Developments III-25
B. Market Analytics III-26
Table 20: Canadian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-26
Table 21: Canadian 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-27

3. Japan III-28

A. Market Analysis III-28
Cell and Tissue Culture Market III-28
Biotechnology Industry in Japan III-28
Strategic Development III-28
B. Market Analytics III-29
Table 22: Japanese Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-29
Table 23: Japanese 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-29

4. Europe III-30

A. Market Analysis III-30
Biotech and Life-Science Research III-30
Market Overview III-30
B. Market Analytics III-31
Table 24: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Geographic Region - France, Germany, UK, Italy & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-31
Table 25: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-32
Table 26: European 10-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for France,
Germany, UK, Italy & Rest of Europe Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-32
Table 27: European 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera,
and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-33

4a. France III-34

A. Market Analysis III-34
B. Market Analytics III-34
Table 28: French Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-34
Table 29: French 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera,
and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-35

4b. Germany III-36

A. Market Analysis III-36
Biotech Research Scenario III-36
Table 30: German Biotech Market: Percentage Share in 2004 by Application Area for Environment, Human Health Care, Chemical industry, Food, Agriculture, Energy, and Others (includes corresponding Graph/Chart) III-37
PromoCell - A Key Player III-37
Strategic Developments III-37
B. Market Analytics III-39
Table 31: German Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-39
Table 32: German 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-40

4c. The United Kingdom III-41

A. Market Analysis III-41
Cell and Tissue Culture Market III-41
Biotechnology Industry - A Brief Insight III-41
Research Entities III-41
Commercial Activities III-41
Outlook III-41
Regulatory Issues III-42
HFE Act Guidelines III-42
The Ethical Issues III-42
Sera Laboratories International- A Key Player III-43
Strategic Corporate Developments III-43
Product Launches III-43
B. Market Analytics III-44
Table 33: UK Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-44
Table 34: UK 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-44

4d. Italy III-45

A. Market Analysis III-45
B. Market Analytics III-45
Table 35: Italian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-45
Table 36: Italian 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-46

4e. Rest of Europe III-47

A. Market Analysis III-47
Cell and Tissue Culture Market III-47
Scenario in other European Countries III-47
Key Players III-47
Cell Culture Technologies (Switzerland) III-47
Medi-Cult (Denmark) III-48
PerBio Science (Sweden) III-48
Vitrolife AB (Sweden) III-48
Strategic Developments III-48
B. Market Analytics III-51
Table 37: Rest of Europe Market for Cell/Tissue Culture Supplies - Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-51
Table 38: Rest of Europe 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera
and Reagent Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-51

5. Asia-Pacific III-52

A. Market Analysis III-52
Overview III-52
India III-52
China III-52
Taiwan III-53
Australia III-53
Strategic Developments III-53
B. Market Analytics III-55
Table 39: Asia-Pacific Market for Cell/Tissue Culture Supplies - Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-55
Table 40: Asia-Pacific 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-55

6. Latin America III-56

A. Market Analysis III-56
Cell and Tissue Culture Market III-56
Brazilian Biotech Industry III-56
B. Market Analytics III-56
Table 41: Latin American Market for Cell/Tissue Culture Supplies - Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-56
Table 42: Latin American 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-57

IV. COMPETITION

1. Aastrom Biosciences, Inc. (USA) IV-1
Table 43: Annual Sales Analysis: 2004-2006 (In US$ million) IV-2
2. ABgene (UK) IV-4
3. Acolyte Biomedica Limited (UK) IV-5
4. Advanced Biotechnologies, Inc. (USA) IV-7
5. American Type Culture Collection (USA) IV-10
6. Amphioxus Cell Technologies, Inc. (USA) IV-14
7. Amresco, Inc. (USA) IV-15
8. Analytical Biological Services, Inc. (USA) IV-16
9. Australian Stem Cell Centre (ASCC) (Australia) IV-17
10. Barloworld Scientific Ltd. (UK) IV-18
Techne, Inc. (USA) IV-20
R&D Systems, Inc. (USA) IV-22
11. Barnstead International (USA) IV-24
12. Becton Dickinson and Company (USA) IV-26
Table 44: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-28
Table 45: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-28
Table 46: Annual Sales Analysis: 2004-2005 (In US$ million) IV-28
BD Biosciences (USA) IV-31
13. Bellco Glass, Inc. (USA) IV-33
14. Biochrom AG (Germany) IV-33
15. Biocientifica SA (Argentina) IV-34
16. BioCrystal Limited (USA) IV-35
17. Biodesign International (USA) IV-37
18. Biohit PLC (Finland) IV-40
Table 47: Annual Sales Analysis: 2004-2005 (In € million) IV-40
Table 48: Annual Sales Analysis by Segment: 2004-2005 (In € million) IV-40
19. Biological Industries (Israel) IV-43
20. Biomedical Technologies, Inc. (USA) IV-44
21. Bio-Rad Laboratories, Inc. (USA) IV-46
Table 49: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-47
Table 50: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-48
Table 51: Annual Sales Analysis: 2004-2005 (In US$ million) IV-48
Table 52: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-48
Table 53: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-48
Table 54: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-48
22. Biotage LLC (USA) IV-53
23. Biowest (France) IV-54
24. Boston Scientific Corporation (USA) IV-56
Table 55: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ billion) IV-58
Table 56: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ billion) IV-58
Table 57: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In US$ billion) IV-58
Table 58: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ billion) IV-58
Table 59: Annual Sales Analysis: 2004-2005 (In US$ billion) IV-59
Table 60: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ billion) IV-59
Table 61: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion) IV-59
Table 62: Annual Sales Analysis by Quarter: 2004-2005 (In US$ billion) IV-59
25. Brandtech Scientific, Inc. (USA) IV-69
26. Calbatech, Inc. (USA) IV-71
Table 63: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-72
Table 64: Annual Sales Analysis: 2004-2005 (In US$ million) IV-72
27. Cambrex Bio Science Walkersville (USA) IV-73
28. Cell Applications, Inc. (USA) IV-74
29. Cell Culture Technologies (Switzerland) IV-75
30. Cell Essentials, Inc. (USA) IV-77
31. Cell Sciences, Inc. (USA) IV-78
32. Cellartis AB (Sweden) IV-79
33. Cellca GmbH (Germany) IV-80
34. Cellntec Advanced Cell Systems AG (Switzerland) IV-81
35. Cellontech Co., Ltd. (Korea) IV-82
36. Cellzdirect, Inc. (USA) IV-83
37. Centerchem, Inc. (USA) IV-84
38. Chemicon International, Inc. (USA) IV-86
39. Chugai Pharmaceutical Co., Ltd. (Japan) IV-91
Table 65: First Quarter Sales Analysis: 2005-2006 (In ¥ million) IV-91
Table 66: Annual Sales Analysis: 2004-2005 (In ¥ million) IV-92
40. Clinical Cell Culture Ltd. (UK) IV-95
41. Commonwealth Biotechnologies, Inc. (USA) IV-97
Table 67: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ thousands) IV-98
Table 68: Half Yearly Sales Analysis by Operations: 2005-2006 (H1) (In US$ thousands) IV-98
42. Conception Technologies (USA) IV-101
43. Corning, Inc. (USA) IV-103
Table 69: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-105
Table 70: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-105
Table 71: Annual Sales Analysis: 2004-2005 (In US$ million) IV-105
Table 72: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-105
Table 73: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-106
Table 74: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-106
44. Coy Laboratory Products, Inc. (USA) IV-110
45. CSL Biosciences (Australia) IV-111
Table 75: Annual Sales Analysis: 2005-2006 (In A$ million) IV-111
Table 76: Annual Sales Analysis by Geographic Region: 2005-2006 (In A$ million) IV-112
46. Digene Corporation (USA) IV-113
Table 77: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended March) (In US$ million) IV-114
Table 78: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-114
47. Don Whitley Scientific Ltd. (UK) IV-117
48. Drummond Scientific Co. (USA) IV-118
49. Essen Instruments (USA) IV-119
50. Fertipro NV (Belgium) IV-120
51. Gemini Bio-Products (USA) IV-121
52. Genetix Ltd. (UK) IV-123
Table 79: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million) IV-123
Table 80: Annual Sales Analysis: 2004-2005 (In £ million) IV-124
53. Genzyme Corporation (USA) IV-125
Table 81: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-128
Table 82: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-128
Table 83: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-128
Table 84: Annual Sales Analysis: 2004-2005 (In US$ million) IV-128
Table 85: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-128
Table 86: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-129
Table 87: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion) IV-129
54. Globepharm Ltd. (UK) IV-134
55. Greiner Bio-One GmbH (Germany) IV-135
56. GroPep Limited (Australia) IV-138
Table 88: Annual Sales Analysis: 2005-2006 (In A$ million) IV-140
Table 89: Annual Sales Analysis by Business Segment: 2005-2006 (In A$ million) IV-140
57. Grupo Grifols (Spain) IV-142
58. Harvard Bioscience, Inc. (USA) IV-150
Table 90: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-153
Table 91: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-153
Table 92: Annual Sales Analysis: 2004-2005 (In US$ million) IV-154
Table 93: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-154
Table 94: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-154
59. Imgenex Corporation (USA) IV-156
60. Integra Biosciences AG (Switzerland) IV-158
61. Invitrogen Corporation (USA) IV-159
Table 95: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-160
Table 96: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-160
Table 97: Annual Sales Analysis: 2004-2005 (In US$ million) IV-160
Table 98: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-160
Table 99: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-161
Biofluids/Invitrogen-Gibco (USA) IV-167
Bioreliance Corporation (USA) IV-167
Biosource International, Inc. (USA) IV-168
Biosource Europe SA (Belgium) IV-169
62. Irvine Scientific, Inc. (USA) IV-170
63. Kemp Biotechnologies (USA) IV-171
64. Kimble Kontes Glass, Inc. (USA) IV-172
65. Leica Microsystems, Inc. (USA) IV-173
66. Mandel Scientific Company, Inc. (Canada) IV-176
67. Mediatech, Inc. (USA) IV-177
68. Medi-Cult A/S (Denmark) IV-178
69. Midwest Scientific (USA) IV-183
70. Millenium Biologix Corporation (USA) IV-184
Table 100: First Quarter Sales Analysis: 2006-2007 (In US$ million) IV-185
Table 101: First Quarter Sales Analysis by Segment: 2006-2007 (In US$ million) IV-185
71. Millipore Corporation (USA) IV-189
Table 102: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-190
Table 103: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-190
Table 104: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-190
Table 105: Annual Sales Analysis: 2004-2005 (In US$ million) IV-190
Table 106: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-190
Table 107: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-191
Table 108: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-191
Celliance Corporation/Millipore' s Bioprocess Division (USA) IV-196
72. Minerva Biolabs GmbH (Germany) IV-198
73. MP Biomedicals (USA) IV-199
74. Nalge Nunc International, Inc. (USA) IV-201
75. New Brunswick Scientific Co., Inc. (USA) IV-202
Table 109: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-203
Table 110: Annual Sales Analysis: 2004-2005 (In US$ million) IV-203
Table 111: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-203
Table 112: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-203
76. Nikon Corporation (Japan) IV-206
Table 113: Annual Sales Analysis: 2004-2006 (In ¥ million) IV-209
Table 114: Annual Sales Analysis by Segment: 2005-2006 (In ¥ million) IV-209
Table 115: Annual Sales Analysis by Geographic Region: 2005-2006 (In ¥ million) IV-209
Table 116: Annual Sales Analysis by Segment: 2004-2005 (In ¥ million) IV-210
Table 117: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ million) IV-210
77. Osiris Therapeutics, Inc. (USA) IV-216
Table 118: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-217
78. Pall Corporation (USA) IV-219
Table 119: Annual Sales Analysis: 2004-2006 (In US$ million) IV-221
Table 120: Annual Sales Analysis by Segment: 2005-2006 (In US$ million) IV-221
Table 121: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-221
Table 122: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-221
Table 123: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-222
79. Para Scientific Company (USA) IV-225
80. ProBioGen AG (Germany) IV-226
81. Promocell GmbH (Germany) IV-227
82. Quality Biological, Inc. (USA) IV-227
83. ReNeuron Ltd. (UK) IV-228
84. Rentschler Biotechnologie (Germany) IV-229
85. Research Organics, Inc. (USA) IV-230
86. Roche Molecular Biochemicals (USA) IV-230
87. Sartorius AG (Germany) IV-231
Table 124: Annual Sales Analysis: 2004-2005 (In € million) IV-232
Sartorius BBI Systems GmbH (Germany) IV-233
Sartorius BBI Systems, Inc. (USA) IV-234
Sartorius Vivascience GmbH (Germany) IV-234
88. SC Proven (UK) IV-235
89. Scientific Industries, Inc. (USA) IV-236
Table 125: Annual Sales Analysis: 2005-2006 (In US$ thousands) IV-236
90. Sentigen Holding Corporation (USA) IV-238
Table 126: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-239
Table 127: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-239
Table 128: Half Yearly Sales Analysis by Business Operation: 2005-2006 (H1) (In US$ million) IV-239
Table 129: Annual Sales Analysis: 2004-2005 (In US$ million) IV-239
Table 130: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-239
Table 131: Annual Sales Analysis by Business Operation: 2004-2005 (In US$ million) IV-240
Sentigen Biosciences (USA) IV-240
Cell And Molecular Technologies, Inc. (USA) IV-241
91. Sera Laboratories International Ltd. (UK) IV-242
92. Serotec Ltd. (UK) IV-242
93. Sigma-Aldrich Corporation (USA) IV-243
Table 132: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-244
Table 133: First Quarter Sales Analysis by Segment: 2005-2006 (In US$ million) IV-244
Table 134: First Quarter Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-244
Table 135: Annual Sales Analysis: 2004-2005 (In US$ million) IV-244
Table 136: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-244
Table 137: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-245
Table 138: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-245
SAFC Biosciences (USA) IV-253
Sigma-Aldrich Co., Ltd. (UK) IV-254
94. Spectrocell (USA) IV-255
95. Spectrum Laboratory Products Inc. (USA) IV-256
96. Stem Cell Sciences PLC (UK) IV-257
Table 139: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million) IV-257
97. Stratagene, Inc. (USA) IV-259
Table 140: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-261
Table 141: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-261
Table 142: Annual Sales Analysis: 2004-2005 (In US$ million) IV-261
Table 143: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-261
Table 144: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-261
Table 145: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-262
98. Surmodics, Inc. (USA) IV-265
Table 146: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-265
Table 147: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-266
Table 148: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-266
Table 149: Annual Sales Analysis: 2004-2005 (In US$ million) IV-266
Table 150: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-266
Table 151: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-266
99. The Automation Partnership (TAP) (UK) IV-269
100. The Binding Site, Inc. (USA) IV-270
101. Thermo Fisher Scientific, Inc. (USA) IV-271
Table 152: Annual Sales Analysis: 2004-2005 (In US$ million) IV-272
Cole-Parmer Instrument Co. (USA) IV-277
PerBio Science AB (Sweden) IV-279
Hyclone Laboratories, Inc. (USA) IV-281
102. Thomas Scientific (USA) IV-283
103. USA Scientific, Inc. (USA) IV-283
104. USB Corporation (USA) IV-284
Table 153: Annual Sales Analysis: 2004-2005 (In US$ million) IV-284
105. Ventria Bioscience (USA) IV-285
106. Vitrolife AB (Sweden) IV-286
107. Wave Biotech LLC (USA) IV-289
108. Whatman PLC (UK) IV-290
Table 154: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million) IV-291
Table 155: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In £ million) IV-291
Table 156: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In £ million) IV-291
Table 157: Annual Sales Analysis: 2004-2005 (In £ million) IV-291
Table 158: Annual Sales Analysis by Segment: 2004-2005 (In £ million) IV-291
Table 159: Annual Sales Analysis by Geographic Region: 2004-2005 (In £ million) IV-292
109. Wheaton Science Products (USA) IV-293
110. Wisent, Inc. (Canada) IV-293

細胞と組織培養関連サプライの世界市場：戦略分析と将来予測

CELL/TISSUE CULTURE SUPPLIES

Abstract

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. Market Dynamics II-1

2. Trends and Issues II-4

3. End Use Analysis II-10

4. Cell/Tissue Culture: Physiological Overview II-14

6. Product Introductions/Innovations II-34

7. Recent Industry Activity II-38

8. Focus on Select Major Players II-51

9. Global Market Perspective II-57

II. MARKET

2. Canada III-25

3. Japan III-28

4. Europe III-30

4a. France III-34

4b. Germany III-36

4c. The United Kingdom III-41

4d. Italy III-45

4e. Rest of Europe III-47

5. Asia-Pacific III-52

6. Latin America III-56

IV. COMPETITION